Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer
The DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index.
Abstract
First described over 80 years ago, ataxia-telangiectasia (A-T) was defined as a clinical entity 50 years ago. Although not encountered by most clinicians, it is a paradigm for cancer predisposition and neurodegenerative disorders and has a central role in our understanding of the DNA-damage response, signal transduction and cell-cycle control. The discovery of the protein A-T mutated (ATM) that is deficient in A-T paved the way for rapid progress on understanding how ATM functions with a host of other proteins to protect against genome instability and reduce the risk of cancer and other pathologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p53 (TP53), which is a major target of the PI3K-related protein kinases (PI3K) ATM and ATR and that plays a pivotal role in DDR 5”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [5]
In the citing paper
“ATM is a defective gene in Ataxia-telangiectasia (A-T), an autosomal recessive disorder with early onset progressive cerebellar ataxia, oculocutaneous telangiectasia, and lymphoid tumor susceptibility [48, 49].”
From Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress (2014) · cites this paper as [48]
Citations
Cites
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466 · cited 1×
“Indeed, chloroquine and other agents that alter chromatin structure can cause partial activation of ATM in the absence of DNA DSB”
BackgroundATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075 · cited 1×
“ATM has multiple substrates — indeed, recent proteomic analysis of phosphoproteins induced by DNA damage suggest that the ATM and ATR network might have as many as 700 substrate”
BackgroundKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 1×
“This was not surprising, because the stabilization and activation of p53 was defective in A-T cells, and these cells were also characterized by a defective G1–S checkpoint, in which p53 has a central rol”
BackgroundA Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
Self-citationActivation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
An Oncogene-Induced DNA Damage Model for Cancer Development
Halazonetis, T. D., Gorgoulis, V. G., & Bartek, J. (2008) · Science · doi:10.1126/science.1140735 · Cited by 1,851 · cited 1×
“DNA breaks per se can also be beneficial in that they activate a DNA-damage response in pre-cancerous cells, thereby establishing a barrier to tumour progressio”
BackgroundATR: an essential regulator of genome integrity
Cimprich, K. A., & Cortez, D. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2450 · Cited by 1,798
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Research works printed but not linked: 2
- Syllaba, K. & Henner, K. Contribution a l'independence de l'athetose double idiopathique et congenitale. Atteinte familiale, syndrome dystrophique, signe de reseau vasculaire conjonctival, integrite psychique. Rev. Neurol. 1, 541–562 (1926) (in French).
- Digweed, M., Reis, A. & Sperling, K. Nijmegen breakage syndrome: consequences of defective DNA double strand break repair. Bioessays 21, 649–656 (1999). · doi:10.1002/(sici)1521-1878(199908)21:8<649::aid-bies4>3.0.co;2-o
Cited by
Items 801–898 of 898
Stochastic Oscillations in Living Cells
Fakultät, L. (2015)
Palchik, G. A. (2013) · DigitalGeorgetown (Georgetown University Library)
From Pathogenesis to Treatment of Chronic Lymphocytic
Zenz, T., Mertens, D., Küppers, R., Döhner, H., Stilgenbauer, S., & Zenz, L. (2010)
Disorders of DNA Repair and Metabolism
Plon, S. E. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00177-4
ОНТОЛОГІЧНА МОДЕЛЬ ПРОЦЕСІВ ПРОГРАМОВАНОЇ КЛІТИННОЇ ЗАГИБЕЛІ
Mintser, O. P., & Vatlitsov, D. V. (2015) · Medical Informatics and Engineering · doi:10.11603/mie.1996-1960.2015.2.4906
Li, X. (2012) · cIRcle (University of British Columbia) · doi:10.14288/1.0072731
Induced Pluripotent Stem Cells (iPSCs) to Study and Treat Movement Disorders
Datta, D., & Kim, K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00009-3
Antonio, D. A. V., & Bosch, L. (2010)
The Protumorigenic Role of Caspase-8 in Neuroblastoma
Twitchell, D. D. (2013) · doi:10.21007/etd.cghs.2013.0327
Radiosensitizing Glioma by Targeting ATM with Small Molecule Inhibitors
Sule, A. D., & Valerie, K. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-45594-5_12
Clinical Implications of Pharmacogenetic Data
Chiara, G. (2012)
Estudio de las fosfatasas hCdc14 en el ciclo de división celular y en la respuesta al daño en el DNA
de la Roca, P. A. (2015) · Gredos (University of Salamanca) · doi:10.14201/gredos.127302
Monitoring DNA Repair Consequences of ATM Signaling Using Simultaneous Fluorescent Readouts
Wiegmans, A. P. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6955-5_24
Analyzing ATM Function by Electroporation of Endonucleases and Immunofluorescence Microscopy
Suzuki, K. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6955-5_7
Measurement of sensitivity to DNA damaging agents
Sherin Mathew, T. (2017)
ChunQing, W. A. N. G., Wang, H., & RuiBing, C. H. E. N. (2017) · Scientia Sinica Vitae · doi:10.1360/n052017-00147
Fontugne, J. (2017) · Molecular pathology library · doi:10.1007/978-3-319-64096-9_23
Hypoxia and the DNA Damage Response
Pires, I. M., Poole, R. L., & Hammond, E. M. (2010) · Wiley eBooks · doi:10.1002/9780470669891.ch10
Pre-clinical Profile and Expectations for Pharmacological ATM Inhibition
Weber, A. M., & Ryan, A. J. (2018) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-75836-7_7
Fernández-Díez, C. (2017) · Buleria (Universidad de León) · doi:10.18002/10612/7072
Gomez, R. O. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2018.tde-25042018-163036 · Cited by 1
A Novel Role of the p53 Tumor Suppressor Pathway in Maintaining Glucose Homeostasis
Franck, D.-A., & Tracy, L. (2010) · Digital WPI
Mangalhara, K. C., & Bamezai, R. N. K. (2019) · Springer eBooks · doi:10.1007/978-981-13-3585-3_11
Gene editing in PRKDC severe combined immunodeficiency and ataxia telangiectasia
Prakash, V. (2017) · Cited by 1
Muthuswami, R. (2020) · Springer eBooks · doi:10.1007/978-981-32-9005-1_8
Phospho-regulation of the DNA Damage Response Kinase ATR
Nam, E. A. (2011) · Cited by 1
Classification of genetic variants in hereditary cancer genes
Feliubadaló, L., Parsons, M. T., Pineda, M., & Tudini, E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820519-8.00003-x
Ataxia-Telangiectasia in Cameroonian Children
Enyama, D., Kana, C. A. N., Kouam, J. M., Njinkui, D. N., Lekpa, F. K., Mbonda, P. C., Kedy, D. C., Mbonda, E., & Nguefack, S. (2021) · Pediatric Oncall · doi:10.7199/ped.oncall.2021.25
Human diseases associated with genome instability
Kovalchuk, I. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85679-9.00025-8 · Cited by 1
Role of Histone Metabolism and Chromatin Structure in DNA Repair
Kari, V. (2014) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4552
MicroRNA, DNA Repair, and Cancer
Hu, H. (2014) · Springer eBooks · doi:10.1007/978-1-4899-8065-6_3
Chromatin remodeling in the UV-induced DNA damage response
Aydın, Ö. Z. (2014) · RePub (Erasmus University Rotterdam)
Pizarro, J. G., Camins, A., Junyent, F., Verdaguer, E., Auladell, C., Beas‐Zárate, C., Pallàs, M., & Folch, J. (2012) · Springer eBooks · doi:10.1007/978-94-007-4213-0_11
Role of Mitochondrial Dynamics and Autophagy in Removal of Helix-Distorting Mitochondrial DNA Damage
Bess, A. S. (2012) · DukeSpace (Duke University)
Neuroimaging and Sonography of Neurocutaneous Disorders
Panteliadis, C. P., Hagel, C., Hofstadler, B., Bendszus, M., Godel, T., Kaplan, S. L., & Zandifar, A. (2022) · Springer eBooks · doi:10.1007/978-3-030-87893-1_3
Heterogeneity in BIRC3 and ATM Alterations in del(11q) Chronic Lymphocytic LeukemiaPreprint
Galvano, C., Krzywinski, A., Stanganelli, C., Rodríguez, C., Heller, V. B., Miodosky, M., Cugliari, S., Bezares, R. F., & Slavutsky, I. R. (2022) · Research Square · doi:10.21203/rs.3.rs-1333170/v1
(2012) · Wiley eBooks · doi:10.1002/9781119977452.refs
The tumour suppressor p53 as a supporter of DNA replication
Klusmann, I. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7143
Monsalve, D. M. (2014) · Gredos (University of Salamanca) · doi:10.14201/gredos.124182 · Cited by 1
Pulmonary Complications of Primary Immunodeficiencies
Routes, J. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-4710-0.00082-1
Cubo, E., & Goetz, C. G. (2014) · Encyclopedia of the Neurological Sciences · doi:10.1016/b978-0-12-385157-4.00007-5
Disorders of DNA Repair and Metabolism
Plon, S. E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.05515-x
Staudt, D. E., Murray, H. C., Skerrett-Byrne, D. A., Smith, N. D., Jamaluddin, M. F. B., Kahl, R. G. S., Duchatel, R. J., Germon, Z. P., McLachlan, T., Jackson, E. R., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.22.489124
Characterisation of the role of the ATR kinase homolog in L. major response to replication stress
da Silva, G. L. A. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2022.tde-01122022-121302
Immunodeficiency, Leukemia, and Lymphoma
Srinivasan, A., Sinha, A. A., & Frazer, J. K. (2022) · Interdisciplinary cancer research · doi:10.1007/16833_2022_82
Data from The Limitations of the G1-S Checkpoint
Deckbar, D., Stiff, T., Koch, B., Reis, C., Löbrich, M., & Jeggo, P. A. (2023) · doi:10.1158/0008-5472.c.6500090.v1
Golding, S. E., Rosenberg, E., Valerie, N. C. K., Hussaini, I. M., Frigerio, M., Cockcroft, X. F., Chong, W. Y., Hummersone, M., Rigoreau, L. J. M., Menear, K. A., et al. (2023) · doi:10.1158/1535-7163.c.6532065
The mechanism accounting for DNA damage strength modulation of p53 dynamical properties
Ma, A., & Dai, X. (2023) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720023500117
Cecchini, M., Zhang, J. Y., Wei, W., Sklar, J., Lacy, J., Zhong, M., Kong, Y., Zhao, H., DiPalermo, J., Devine, L., et al. (2023) · doi:10.1158/2767-9764.23593088
Familial Non-medullary Thyroid Cancer
Kłubo-Gwieździńska, J., Kushchayeva, Y., Gara, S. K., & Kebebew, E. (2023) · Springer eBooks · doi:10.1007/978-3-031-38605-3_17
Tatfi, M., Perthame, É., Hillion, K.-H., Dillies, M., Ménager, H., Hermine, O., & Suárez, F. (2021) · Figshare · doi:10.6084/m9.figshare.14870608
Tatfi, M., Perthame, É., Hillion, K.-H., Dillies, M., Ménager, H., Hermine, O., & Suárez, F. (2021) · Figshare · doi:10.6084/m9.figshare.14870620
Tatfi, M., Perthame, É., Hillion, K.-H., Dillies, M., Ménager, H., Hermine, O., & Suárez, F. (2021) · Figshare · doi:10.6084/m9.figshare.14870614
ATM Kinase Small Molecule Inhibitors Prevent Radiation-Induced Apoptosis of Mouse Neurons In Vivo
Aydar, Y., Rambukkanage, S. S., Brown, L., Wang, J., Seo, J. S., Li, K., Cheng, Y., Biddlestone-Thorpe, L., Boyd, C., Sule, A. D., et al. (2024) · Kinases and Phosphatases · doi:10.3390/kinasesphosphatases2030017
Letterio, J. J., & Ahuja, S. P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-12260-6.00019-5
Leem, J., & Oh, J. S. (2025) · Springer eBooks · doi:10.1007/978-3-031-97173-0_5
Elmakhzen, B., & Anass, E. A. (2025) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2025.27.2.3077
Nikpour, P., Varas‐Godoy, M., Tenghamn, J., Uhlén, P., & Smedler, E. (2026) · iScience · doi:10.1101/2025.10.10.676024
Localisation et fonction de CHK2 en mitose
Chouinard, G. (2012) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/31174
Characterisation of UVA-induced DNA damage responses in human skin cells
Conmy, S. A. (2013) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/16394
Staudt, D. E., Murray, H. C., Skerrett-Byrne, D. A., Smith, N. D., Jamaluddin, M. F. B., Kahl, R. G. S., Duchatel, R. J., Germon, Z. P., McLachlan, T., Jackson, E. R., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22607050
Tatfi, M., Perthame, É., Hillion, K.-H., Dillies, M., Ménager, H., Hermine, O., & Suárez, F. (2021) · Figshare · doi:10.6084/m9.figshare.14870611
Tatfi, M., Perthame, É., Hillion, K.-H., Dillies, M., Ménager, H., Hermine, O., & Suárez, F. (2021) · Figshare · doi:10.6084/m9.figshare.14870617
Tatfi, M., Perthame, É., Hillion, K.-H., Dillies, M., Ménager, H., Hermine, O., & Suárez, F. (2021) · Figshare · doi:10.6084/m9.figshare.14870623
Tatfi, M., Perthame, É., Hillion, K.-H., Dillies, M., Ménager, H., Hermine, O., & Suárez, F. (2021) · Figshare · doi:10.6084/m9.figshare.14870605
SCF-FBXO31 E3 ubiquitin ligase in cancer: Molecular insights and clinical implications
Sahay, O., Behera, A., Biswas, C., Barik, G. K., & Islam, S. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189534
Targeting DNA damage response pathways in cancer
Torrado, C., Tan, H. N., & Yap, T. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00075-3
Escobar, P. A. (2010) · theses.fr (ABES) · doi:10.70675/6ef77dc7ze8f2z4d7bza761zc1f42658f0a5
Ferdousi, L. V. (2014) · theses.fr (ABES) · doi:10.70675/9d73199ez7949z4602zadcfz6763e4bdd1b0
Cristini, A. (2015) · theses.fr (ABES) · doi:10.70675/89719cadza51cz4509zbd9fz3da99c280491
Caractérisation fonctionnelle de la tolérance aux endommagements de l’ADN des embryons précoces
Furno, E. L. (2019) · theses.fr (ABES) · doi:10.70675/cf32bcd5z3031z4693z8b1bz62fe76673ccc
Rôle de la protéine ATM dans la régulation des gènes de latences du virus d’Epstein-Barr (EBV)
Tatfi, M. (2019) · theses.fr (ABES) · doi:10.70675/3b654584z65a5z4cbbzbbc2zde0a759cf1ab
Microcéphalie et anomalie de l'hématopoïèse : étude d'un modèle de souris Mcph1 knock-out
Vial, Y. (2021) · theses.fr (ABES) · doi:10.70675/09d99062z97f7z461dz9b9ez42f7ab1f5ad4
Étude du rôle des protéines Ribonucléases H dans la réponse cellulaire au stress réplicatif
Kemiha, S. (2022) · theses.fr (ABES) · doi:10.70675/838e1563z0a0ez4ecdza7c4zc6dc0a36d63f
Mai, L., Smirnov, A., Allers, M. M., Song, Z., Liu, M., Trinh, T., Brons, S., Weykamp, F., Liermann, J., Perez, R. L., et al. (2026) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2026.101225
“We also investigated ATM-kinase activation as a key mediator of cellular DNA-repair responses [63].”
Rossmanith, R., Wolf, H. M., & Geier, C. B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1865775
“In these conditions, immune dysfunction is more directly linked to defective DNA double-strand break sensing or repair, impaired V(D)J recombination, abnormal lymphocyte development, radiosensitivity, or combined immunode fi ciency (64 – 68).”
The RNA-binding protein RALY promotes ATM activation by stabilizing Tip60
Yao, B., Zhao, K., Yu, N., Wang, N., Chang, Y., Luo, L., Wang, F., & Mei, Y. (2026) · Oncogene · doi:10.1038/s41388-026-03904-8
Yang, Q., Xing, X., Wang, Y., Wang, X., Han, Y., Ren, J., Zhang, Z., Tang, J., & Zhao, J. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02739-x
Ma, Y., Li, X., Chen, H., & Fan, R. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1772217
“…which is made up of RAD50, NBS1, and MRE11, ATM carries out a process called phosphorylation on a variety of other proteins that play a role in DNA DDR, as previously stated (Blackford and Jackson, 2017; Lavin, 2008; Shiloh, 2003; Ciccia and Elledge, 2010; Banin et al., 1998; Bassing et al., 2003).”
Recent Advances in Therapy for the Neurodegenerative Disorder Ataxia-Telangiectasia
Nayler, S., Foster, S. R., Lavin, M. F., & Coman, D. J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167347
“This syndrome is characterised by progressive cerebellar degeneration, oculocutaneous telangiectasia, bronchopulmonary disease, elevated risk of lymphoid and other forms of cancer, immunodeficiency, infertility and clinical radiosensitivity [2,3] (Figure 1).”
Self-citationProteomics in Ataxia Telangiectasia Fibroblasts Revealed Disease Hallmarks Recovered by ATM Variants
Ricci, A., Biancucci, F., Morganti, G., Iqbal, M. J., Monittola, F., Magnani, M., Crinelli, R., & Menotta, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188084
“The hallmark telangiectasias, or dilated blood vessels, typically develop in the eyes and on the skin, further complicating diagnosis [6–9].”
Classic Ataxia–Telangiectasia associated with a homozygous missense ATM variant: A case report
Al-Frejat, Z., Azzam, L., Hanna, G., Hamza, D. A., & Alkhayer, G. (2026) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2026.101363
“Loss of ATM function leads to genomic instability and contributes to the wide spectrum of clinical manifestations observed in affected individuals [3].”
DNA damage response associated miRNA dysregulation in Ataxia-telangiectasia
Iqbal, M. J., Bucci, C., Ricci, A., Morganti, G., Khan, F. I., Khan, M. J., & Menotta, M. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12860-1
Iqbal, M. J., Azhar, M., Hassan, A., & Menotta, M. (2026) · The Cerebellum · doi:10.1007/s12311-026-02108-w
Raposo, T. M. M. (2013) · Americanae (AECID Library)
Gonon, G. (2011) · theses.fr (ABES) · doi:10.70675/48b4a8c9zf975z4e6fz861fz006708fb3d2a · Cited by 1
The interaction of CtIP with DNA damage response proteins
Abramowiçz, I. (2010) · University of Birmingham Institutional Research Archive (University of Birmingham)
MYCN and microRNAs in neuroblastoma
Büchner, J. (2011) · NORA - Norwegian Open Research Archives
Metadata
- Authors
- Lavin, M. F.
- Affiliations
- QIMR Berghofer Medical Research Institute (AU)
- Corresponding author
- Lavin, Martin F.
- ORCID
- Lavin, Martin F.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2008-10
- Volume
- 9
- Issue
- 10
- Pages
- 759-769
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2139777089
- Cited by
- 901
- References
- 126
- Citations by year
- 2026: 15 · 2025: 16 · 2024: 17 · 2023: 19 · 2022: 36 · 2021: 43 · 2020: 36 · 2019: 42 · 2018: 26 · 2017: 54 · 2016: 50 · 2015: 45 · 2014: 63 · 2013: 76 · 2012: 90
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Update notices
- erratum (2008-12-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Keywords
- ataxia telangiectasia, ATM protein, DNA damage response, genomic instability, cancer susceptibility, neurodegenerative diseases, signal transduction, cell cycle regulation
- MeSH terms
- Animals, Ataxia Telangiectasia, DNA Damage, DNA Repair, DNA-Binding Proteins, Humans, Insulin Resistance, Models, Biological, Mutation, Neoplasms, Nerve Degeneration, Protein Processing, Post-Translational, Signal Transduction, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Genetic Predisposition to Disease, Metabolic Syndrome, Tumor Suppressor Proteins, Mice, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.